NEW YORK – Myriad Genetics on Tuesday said it will combine its hereditary cancer risk tests and companion diagnostics in a single offering with tumor tissue profiling services offered through Intermountain Healthcare's Intermountain Precision Genomics service.
To read the full story....
...and receive Weekly News bulletins.
Already have a Precision Oncology News or 360Dx or GenomeWeb account?
Login Now.
Don't have a Precision Oncology News or 360Dx or GenomeWeb account?
Register for Free.